Approval · Notice of Compliance 9328 · 2008
SUPRAX: Notice of Compliance 9328
Issued January 29, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9328
- Date
- January 29, 2008
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a breakability statement (for the 400 mg to support the 200 mg bid dosing schedule)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPRAX | Not yet assigned | — |